SCHEMBL23958652

SCHEMBL23958652

COc1cc(C(=O)NCC(c2cc(C(C)(C)O)c(F)c(-c3ccc(F)cc3)n2)C2CC2)cc2cc(C3CC3)cnc12

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.33
TP53 P04637 1/20 0.33
CFTR P13569 3/20 0.33
ALDH1A1 P00352 2/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
CNR2 P34972 3/20 0.31
CNR1 P21554 1/20 0.31
ROCK2 O75116 1/20 0.31
ROCK1 Q13464 1/20 0.31
KCNH2 Q12809 1/20 0.31
MAPT P10636 2/20 0.31
IRAK4 Q9NWZ3 1/20 0.31
IDO1 P14902 1/20 0.31
ACSS2 Q9NR19 1/20 0.31
KDM4E B2RXH2 1/20 0.30
POLB P06746 1/20 0.30
RECQL P46063 1/20 0.30
FFAR1 O14842 1/20 0.30
HPGDS O60760 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25698171 0.94 PDE4B (0.31) IRAK4ACSS2
SCHEMBL23958776 0.90 LMNA (0.36) LMNATP53CFTRALDH1A1SMN1; SMN2
SCHEMBL23958797 0.90 CFTR (0.36) LMNATP53CFTRALDH1A1SMN1; SMN2
SCHEMBL23958859 0.86 CFTR (0.34) LMNATP53CFTRALDH1A1SMN1; SMN2
SCHEMBL23958874 0.85 CTSA (0.35) ROCK2ROCK1ACSS2FFAR1
SCHEMBL23958810 0.84 CFTR (0.34) LMNATP53CFTRSMN1; SMN2MAPT
SCHEMBL26766103 0.83 IRAK4 (0.39) LMNATP53CFTRKCNH2IRAK4
SCHEMBL30007052 0.82 CFTR (0.34) CFTRSMN1; SMN2CNR2CNR1ROCK2
SCHEMBL25687509 0.82 CFTR (0.34) CFTRSMN1; SMN2CNR2CNR1ROCK2
SCHEMBL25687494 0.82 CFTR (0.37) CFTRSMN1; SMN2CNR2ROCK2ROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021214136-A1 RSV INHIBITING 3-SUBSTITUTED QUINOLINE AND CINNOLINE DERIVATIVES Janssen Sciences Ireland Unlimited Company (IE) 2021-10-28 WO disclosed